Zhu, Xiaoping
Novartis (United States)
2 papers on CoChatORCID 0009-0009-5922-4563
Most cited papers
- Verified
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
Papillon, J. P. N., Nakajima, K., Adair, C. D., Hempel, J., Jouk, A. O., Karki, R. G., Mathieu, S., Möbitz, H., Ntaganda, R., Smith, T., et al. (2018) · Journal of Medicinal Chemistry
Chromatin Remodeling and CancerProtein Degradation and Inhibitors
Cited by 244
- Verified
Old drug new use - Amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity
Kong, R., Liu, T., Zhu, X., Ahmad, S., Williams, A. L., Phan, A. T., Zhao, H., Scott, J. E., Yeh, L.-A., & Wong, S. T. C. (2014) · Clinical Cancer Research
Cancer therapeutics and mechanismsPharmacogenetics and Drug Metabolism
Cited by 90
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free